STAAR Surgical

Monrovia, United States Founded: 1982 • Age: 44 yrs Acquired By Alcon
Manufacturer of implantable lenses for the eye with companion delivery systems
Request Access

About STAAR Surgical

STAAR Surgical is a company based in Monrovia (United States) founded in 1982 was acquired by Alcon in August 2025.. The company has 1,210 employees as of December 31, 2024. STAAR Surgical offers products and services including EVO ICL™, EVO+ ICL™, Visian ICL™, and Collamer Lenses. STAAR Surgical operates in a competitive market with competitors including RxSight, Atia Vision, Nayam Innovations, WaveTec Vision and Wuxi Vision Pro, among others.

  • Headquarter Monrovia, United States
  • Employees 1210 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Staar Surgical Company
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
    $313.9 M
    -2.64
    as on Dec 31, 2024
  • Net Profit
    $-20.21 M
    -194.66
    as on Dec 31, 2024
  • EBITDA
    $-5.72 M
    -117.22
    as on Dec 31, 2024
  • Latest Funding Round
  • Investors
  • Employee Count
    1210

    as on Dec 31, 2024

  • Acquired by
    Alcon

    (Aug 05, 2025)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of STAAR Surgical

STAAR Surgical is a publicly listed company on the NASDAQ with ticker symbol STAA in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NASDAQ · Ticker: STAA . Sector: Health technology · USA

Products & Services of STAAR Surgical

STAAR Surgical offers a comprehensive portfolio of products and services, including EVO ICL™, EVO+ ICL™, Visian ICL™, and Collamer Lenses. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Corrects vision by implantation, reducing need for glasses or contacts.

Advanced lens for vision correction through surgical placement.

Provides visual freedom for myopia and astigmatism patients.

Unique material used in lenses for eye surgery applications.

People of STAAR Surgical
Headcount 500-1000
Employee Profiles 101
Board Members and Advisors 3
Employee Profiles
People
Prajith Maniyath
Sr. Director - IT Enterprise Applications
People
Magda Michna
Chief Clinical, Regulatory & Medical Affairs Officer
People
Warren Foust
COO
People
Christopher Gomez
Quality Engineer I

Unlock access to complete

Funding Insights of STAAR Surgical

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in STAAR Surgical

STAAR Surgical has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Alcon. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Developer of a wide range of eye care products
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by STAAR Surgical

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - STAAR Surgical

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Staar Surgical Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of STAAR Surgical

STAAR Surgical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as RxSight, Atia Vision, Nayam Innovations, WaveTec Vision and Wuxi Vision Pro, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Adjustable intraocular lens technology is developed using UV-sensitive macromers.
domain founded_year HQ Location
A presbyopia-correcting intraocular lens is developed for cataract patients.
domain founded_year HQ Location
Artificial intraocular lenses for cataract treatment are developed.
domain founded_year HQ Location
Intraoperative guidance for IOL alignment in cataract surgery is offered.
domain founded_year HQ Location
Manufacturer of intraocular lenses and related products
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Staar Surgical

Frequently Asked Questions about STAAR Surgical

When was STAAR Surgical founded?

STAAR Surgical was founded in 1982.

Where is STAAR Surgical located?

STAAR Surgical is headquartered in Monrovia, United States. It is registered at Monrovia, California, United States.

How many employees does STAAR Surgical have?

As of Dec 31, 2024, the latest employee count at STAAR Surgical is 1,210.

What is the annual revenue of STAAR Surgical?

Annual revenue of STAAR Surgical is $313.9M as on Dec 31, 2024.

What does STAAR Surgical do?

STAAR Surgical was founded in 1982 and is headquartered in Monrovia, United States. Foldable implantable lenses for the eye, along with companion delivery systems, are produced by the company in the medical device sector. These lenses are designed for insertion through small incisions and address conditions such as cataracts, astigmatism, myopia, and presbyopia. Reliance on glasses or contact lenses is thereby reduced or eliminated through their use.

Who are the top competitors of STAAR Surgical?

STAAR Surgical's top competitors include RxSight, Nayam Innovations and Atia Vision.

What products or services does STAAR Surgical offer?

STAAR Surgical offers EVO ICL™, EVO+ ICL™, Visian ICL™, and Collamer Lenses.

Is STAAR Surgical publicly traded?

Yes, STAAR Surgical is publicly traded on NASDAQ under the ticker symbol STAA.

Who are STAAR Surgical's investors?

STAAR Surgical has 1 investor. Key investors include Alcon.

What is STAAR Surgical's ticker symbol?

The ticker symbol of STAAR Surgical is STAA on NASDAQ.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available